MET and epithelial to mesenchymal transition as novel targets in small cell lung cancer 

Cañadas Castillo, Israel (Date of defense: 2013-06-25)

Small cell lung carcinoma (SCLC) is a highly lethal disease due to its chemorefractory nature after first line treatment. The mechanisms to overcome this resistance have remained elusive to tackle up to date. MET is a ...